739 related articles for article (PubMed ID: 19925959)
21. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
22. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
[TBL] [Abstract][Full Text] [Related]
23. [Tubercular disease: clinical aspects and drug resistance].
Matteelli A; Apostoli A; Benedetti S; Marcantoni C; Carvalho AC
G Ital Med Lav Ergon; 2010; 32(3):260-3. PubMed ID: 21061706
[TBL] [Abstract][Full Text] [Related]
24. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
25. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
26. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
27. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study.
Wang D; Yang C; Kuang T; Lei H; Meng X; Tong A; He J; Jiang Y; Guo F; Dong M
Jpn J Infect Dis; 2010 Sep; 63(5):368-71. PubMed ID: 20859008
[TBL] [Abstract][Full Text] [Related]
29. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
Mitrzyk BM
Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
[TBL] [Abstract][Full Text] [Related]
30. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
[TBL] [Abstract][Full Text] [Related]
31. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
Tabarsi P; Chitsaz E; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Amiri M; Mansouri D; Masjedi MR; Velayati AA; Caminero JA
Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820
[TBL] [Abstract][Full Text] [Related]
32. [Extensively drug-resistant tuberculosis].
Lange C; Grobusch MP; Wagner D
Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922
[TBL] [Abstract][Full Text] [Related]
33. Extensively drug-resistant tuberculosis--United States, 1993-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(11):250-3. PubMed ID: 17380107
[TBL] [Abstract][Full Text] [Related]
34. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India.
Chakraborty N; De C; Bhattacharyya S; Mukherjee A; Santra S; Banerjee D; Sarkar RN; Guha SK
Trans R Soc Trop Med Hyg; 2010 Mar; 104(3):195-201. PubMed ID: 19828165
[TBL] [Abstract][Full Text] [Related]
35. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
[TBL] [Abstract][Full Text] [Related]
36. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
[TBL] [Abstract][Full Text] [Related]
37. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
39. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
[TBL] [Abstract][Full Text] [Related]
40. [Emergence extensive drug resistance tuberculosis (XDR)].
Vier H; Schaberg T; Gillissen A
Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
